Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × Radiotherapy × Clear all

NCT04902040 2026-03-18

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Phase 1/2 Terminated

19 enrolled 11 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

NCT00556621 2015-07-30

GEMCIRAV

Phase 1/2 Completed

Urinary Bladder Neoplasms